On December 3, 2024, Steven Pantelick, the Chief Financial Officer of PubMatic Inc, sold 4,000 shares of the company. Following this transaction, the insider now owns 22,506 shares of PubMatic Inc. The details of this transaction can be found in the SEC Filing.
PubMatic Inc (PUBM, Financial) is a digital advertising technology company that provides a specialized cloud infrastructure platform. This platform enables real-time programmatic advertising transactions, allowing advertisers to reach their target audiences efficiently and effectively.
Over the past year, Steven Pantelick has sold a total of 130,636 shares and has not purchased any shares. The insider transaction history for PubMatic Inc indicates that there have been no insider buys in the past year, while there have been 73 insider sells during the same period.
On the day of the recent sale, shares of PubMatic Inc were trading at $16.56 each, giving the stock a market cap of $809.167 million. The company's price-earnings ratio stands at 54.65, which is higher than the industry median of 27.16 and also higher than the company's historical median price-earnings ratio.
With a trading price of $16.56 and a GuruFocus Value of $21.46, PubMatic Inc has a price-to-GF-Value ratio of 0.77, indicating that the stock is modestly undervalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
